• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.肝细胞癌中的孕激素及相关化合物:基础与临床方面。
Biomed Res Int. 2013;2013:290575. doi: 10.1155/2013/290575. Epub 2013 Jan 16.
2
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.性类固醇受体在肝细胞癌病理生物学中的作用。
World J Gastroenterol. 2008 Oct 21;14(39):5945-61. doi: 10.3748/wjg.14.5945.
3
[HEPATOCELLULAR CARCINOMA. GENDER ASPECTS OF CARCINOGENESIS].[肝细胞癌。致癌作用的性别方面]
Eksp Klin Gastroenterol. 2016(7):4-12.
4
Is human hepatocellular carcinoma a hormone-responsive tumor?人类肝细胞癌是一种激素反应性肿瘤吗?
World J Gastroenterol. 2008 Mar 21;14(11):1682-9. doi: 10.3748/wjg.14.1682.
5
Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma.随机双盲试验:甲地孕酮醋酸酯与安慰剂治疗初治晚期肝细胞癌的疗效比较。
Br J Cancer. 2011 Sep 27;105(7):945-52. doi: 10.1038/bjc.2011.333. Epub 2011 Aug 23.
6
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.以变异雌激素受体为特征的不可切除肝细胞癌的甲地孕酮激素治疗。
Br J Cancer. 2001 Apr 6;84(7):881-5. doi: 10.1054/bjoc.2000.1534.
7
Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells.非肿瘤性和恶性人类肝脏组织及细胞中的雄激素代谢与生物转化
J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):290-5. doi: 10.1016/j.jsbmb.2009.01.013. Epub 2009 Feb 7.
8
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.肠道细菌在合成及天然甾体激素代谢中作用的研究。
J Steroid Biochem. 1984 Jan;20(1):217-29. doi: 10.1016/0022-4731(84)90208-5.
9
Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.Foxa1 和 Foxa2 对于肝癌的性别二态性是必需的。
Cell. 2012 Jan 20;148(1-2):72-83. doi: 10.1016/j.cell.2011.11.026.
10
Potential role of leptin expression in hepatocellular carcinoma.瘦素表达在肝细胞癌中的潜在作用。
J Clin Pathol. 2006 Sep;59(9):930-4. doi: 10.1136/jcp.2005.035477. Epub 2006 Mar 24.

引用本文的文献

1
Whole-Genome Omics Elucidates the Role of CCM1 and Progesterone in Cerebral Cavernous Malformations within CmPn Networks.全基因组组学揭示了CCM1和孕酮在CmPn网络内脑海绵状血管畸形中的作用。
Diagnostics (Basel). 2024 Aug 28;14(17):1895. doi: 10.3390/diagnostics14171895.
2
Sex hormones differently regulate lipid metabolism genes in primary human hepatocytes.性激素对原代人肝细胞中脂质代谢基因的调控作用不同。
BMC Endocr Disord. 2024 Aug 1;24(1):135. doi: 10.1186/s12902-024-01663-9.
3
Animal Models for Studying Congenital Transmission of Hepatitis E Virus.用于研究戊型肝炎病毒先天性传播的动物模型
Microorganisms. 2023 Feb 28;11(3):618. doi: 10.3390/microorganisms11030618.
4
Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers.作为生物标志物的癌症多组学关键成员可区分肝癌的组织学和免疫亚型。
Diagnostics (Basel). 2023 Mar 7;13(6):1012. doi: 10.3390/diagnostics13061012.
5
Naringenin and Quercetin Exert Contradictory Cytoprotective and Cytotoxic Effects on Tamoxifen-Induced Apoptosis in HepG2 Cells.柚皮素和槲皮素对他莫昔芬诱导的 HepG2 细胞凋亡的细胞保护和细胞毒性作用相反。
Nutrients. 2022 Dec 19;14(24):5394. doi: 10.3390/nu14245394.
6
Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma.磷酸葡萄糖酸脱氢酶是肝细胞癌免疫治疗的一种预测性生物标志物。
Front Oncol. 2022 Oct 20;12:993503. doi: 10.3389/fonc.2022.993503. eCollection 2022.
7
Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.月经因素、生育史与肝癌风险:中国女性前瞻性队列研究的结果。
Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2046-2053. doi: 10.1158/1055-9965.EPI-22-0439.
8
The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones.性别和性别相关激素的肝保护和肝毒性作用。
Front Immunol. 2022 Jul 4;13:939631. doi: 10.3389/fimmu.2022.939631. eCollection 2022.
9
Progesterone in gender-affirming therapy of trans women.孕酮在跨性别女性性别肯定治疗中的应用
World J Biol Chem. 2022 May 27;13(3):66-71. doi: 10.4331/wjbc.v13.i3.66.
10
A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma.与基于lncRNA的风险评分相比,三信使RNA状态风险评分在预测肝细胞癌患者预后方面具有更强的预测能力。
Oncol Lett. 2020 Oct;20(4):48. doi: 10.3892/ol.2020.11911. Epub 2020 Jul 24.

本文引用的文献

1
Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers.299 例原发性乳腺癌中孕激素受体异构体与 HER/ErbB 受体及其配体网络的关系。
Int J Biol Markers. 2012 Jul 19;27(2):e111-7. doi: 10.5301/JBM.2012.9198.
2
Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis.肝雄激素受体通过调节细胞迁移和失巢凋亡抑制肝细胞癌转移。
Hepatology. 2012 Jul;56(1):176-85. doi: 10.1002/hep.25644. Epub 2012 Jun 5.
3
Mechanism of exacerbative effect of progesterone on drug-induced liver injury.孕激素增强药物性肝损伤作用的机制。
Toxicol Sci. 2012 Mar;126(1):16-27. doi: 10.1093/toxsci/kfr326. Epub 2011 Dec 7.
4
Minireview: Recent advances in extranuclear steroid receptor actions.综述:核外甾体激素受体作用的最新进展。
Endocrinology. 2011 Dec;152(12):4489-95. doi: 10.1210/en.2011-1470. Epub 2011 Oct 25.
5
Hepatocellular carcinoma.肝细胞癌
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
6
Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma.随机双盲试验:甲地孕酮醋酸酯与安慰剂治疗初治晚期肝细胞癌的疗效比较。
Br J Cancer. 2011 Sep 27;105(7):945-52. doi: 10.1038/bjc.2011.333. Epub 2011 Aug 23.
7
Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.甾体激素受体介导的用于激素替代疗法和避孕的合成孕激素作用的分子机制。
Steroids. 2011 Jun;76(7):636-52. doi: 10.1016/j.steroids.2011.03.001. Epub 2011 Mar 15.
8
Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer.孕激素通过卵巢细胞中的孕激素受体膜成分 1 介导的信号转导,特别强调了在卵巢癌中的作用。
Steroids. 2011 Aug;76(9):903-9. doi: 10.1016/j.steroids.2011.02.011. Epub 2011 Mar 1.
9
Nomegestrol acetate, a novel progestogen for oral contraception.醋酸诺美孕酮,一种新型的口服避孕药孕激素。
Steroids. 2011 May;76(6):531-9. doi: 10.1016/j.steroids.2011.02.002. Epub 2011 Feb 16.
10
Gender disparity of hepatocellular carcinoma: the roles of sex hormones.性别对肝癌的影响:性激素的作用。
Oncology. 2010 Jul;78 Suppl 1:172-9. doi: 10.1159/000315247. Epub 2010 Jul 8.

肝细胞癌中的孕激素及相关化合物:基础与临床方面。

Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects.

机构信息

Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung 83102, Taiwan.

出版信息

Biomed Res Int. 2013;2013:290575. doi: 10.1155/2013/290575. Epub 2013 Jan 16.

DOI:10.1155/2013/290575
PMID:23484104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3581253/
Abstract

Primary liver cancer is the fifth most common cancer worldwide and the third most common cause of cancer mortality. Hepatocellular carcinoma (HCC) accounts for 85% to 90% of primary liver cancers. Major risk factors for HCC include infection with HBV or HCV, alcoholic liver disease, and most probably nonalcoholic fatty liver disease. In general, men are two to four times more often associated with HCC than women. It can be suggested that sex hormones including progesterone may play some roles in HCC. Rather, very limited information discusses its potential involvement in HCC. This paper thus collects some recent studies of the potential involvement of progesterone and related compounds in HCC from basic and clinical aspects. In addition, two synthetic progestins, megestrol acetate (MA) and medroxyprogesterone acetate (MPA), will be discussed thoroughly. It is noted that progesterone can also serve as the precursor for androgens and estrogens produced by the gonadal and adrenal cortical tissues, while men have a higher incidence of HCC than women might be due to the stimulatory effects of androgen and the protective effects of estrogen. Eventually, this paper suggests a new insight on the associations of progesterone and related compounds with HCC development and treatment.

摘要

原发性肝癌是全球第五大常见癌症,也是癌症死亡的第三大主要原因。肝细胞癌 (HCC) 占原发性肝癌的 85%至 90%。HCC 的主要危险因素包括乙型肝炎病毒或丙型肝炎病毒感染、酒精性肝病,以及很可能的非酒精性脂肪性肝病。一般来说,男性患 HCC 的几率是女性的两到四倍。可以认为,包括孕激素在内的性激素可能在 HCC 中发挥一些作用。然而,关于其潜在作用的信息非常有限。本文因此从基础和临床方面收集了一些关于孕激素及相关化合物在 HCC 中潜在作用的最新研究。此外,还将深入讨论两种合成孕激素,醋酸甲地孕酮 (MA) 和醋酸甲羟孕酮 (MPA)。需要注意的是,孕激素也可以作为性腺和肾上腺皮质组织产生的雄激素和雌激素的前体,而男性 HCC 的发病率高于女性,可能是由于雄激素的刺激作用和雌激素的保护作用。最后,本文就孕激素及相关化合物与 HCC 发生和治疗的关联提出了新的见解。